Canada Spends Logo

Explore our Budget 2026 analysis

Grant: China-Canada Joint Health Research Initiative

University of Toronto

$225,000.00

The Role of Chloride Channel ClC-3 in Cerebral Ischemia and Its Therapeutic Potential in Stroke

FY 2012-13

Summary
Stroke is the second leading cause of death in both China and Canada and the leading cause of adult disability in both countries. Its occurrence is expected to triple by 2050, and our aging population is especially vulnerable. The disabilities in afflicted survivors of stroke have created significant social and economic impacts for our society in both countries. For example, with more than 50,000 new strokes occurring each year in Canada, stroke and its related illnesses cost the Canadian healthcare system about $2.5 billion each year according to the 2010 Canadian Stroke Congress. The situation is similar in China, with significant and growing costs to the economy. While stroke poses major health concerns, the mechanisms (causes) leading to brain damage in stroke are not well understood. Our collaborative project focuses on understanding the cellular and molecular mechanisms underlying stroke-related brain injury, particularly the role of anion channel, ClC-3 chloride channel. This channel plays an important role in cell damage during heart ischemia, but its role in brain stroke has not yet been studied. We will study the fundamental role of the ClC-3 chloride channel in brain stroke, and consider new drug development for treating stroke, using a variety of approaches, including molecular biology, biochemistry, in vivo stroke models, histology, advanced imaging, electrophysiology, and functional and behavioural assessments. Our goal is to develop novel therapeutic strategies to prevent brain damage and to promote brain cell survival, regeneration, and functional recovery in the injured brain after stroke, thereby reducing the burden of disease on stroke victims and their families and providing long-term economic, social, and healthcare benefits for both of our countries.
Program
China-Canada Joint Health Research Initiative
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
284865
Name
Sun Hong-Shuo
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
The Role of Chloride Channel ClC-3 in Cerebral Ischemia and Its Therapeutic Potential in Stroke
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$225,000
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Animal Models; Cerebral Ischemia; Cerebrovascular Diseases; Clc-3 Chloride Channels; In-Vivo; Ion Channels; Neuroprotection; Stroke; Treatment; Volume-Regulated Aion Channels
Abstract
Stroke is the second leading cause of death in both China and Canada and the leading cause of adult disability in both countries. Its occurrence is expected to triple by 2050, and our aging population is especially vulnerable. The disabilities in afflicted survivors of stroke have created significant social and economic impacts for our society in both countries. For example, with more than 50,000 new strokes occurring each year in Canada, stroke and its related illnesses cost the Canadian healthcare system about $2.5 billion each year according to the 2010 Canadian Stroke Congress. The situation is similar in China, with significant and growing costs to the economy. While stroke poses major health concerns, the mechanisms (causes) leading to brain damage in stroke are not well understood. Our collaborative project focuses on understanding the cellular and molecular mechanisms underlying stroke-related brain injury, particularly the role of anion channel, ClC-3 chloride channel. This channel plays an important role in cell damage during heart ischemia, but its role in brain stroke has not yet been studied. We will study the fundamental role of the ClC-3 chloride channel in brain stroke, and consider new drug development for treating stroke, using a variety of approaches, including molecular biology, biochemistry, in vivo stroke models, histology, advanced imaging, electrophysiology, and functional and behavioural assessments. Our goal is to develop novel therapeutic strategies to prevent brain damage and to promote brain cell survival, regeneration, and functional recovery in the injured brain after stroke, thereby reducing the burden of disease on stroke victims and their families and providing long-term economic, social, and healthcare benefits for both of our countries.
Competitiondate
201303
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sun, Hong-Shuo; Wang, GUAN-LEI
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $225,000~ $0~
University of Toronto - $225,000 Grant (2012-13) | Canada Spends